CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...
Phase 1, Phase 2
Austin, Texas, United States and 30 other locations
The goal of this platform clinical trial is to test how well novel treatment combinations work in participants with lung cancer. Su ...
Phase 2
Austin, Texas, United States and 67 other locations
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...
Phase 3
Austin, Texas, United States and 230 other locations
This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously...
Phase 3
Austin, Texas, United States and 262 other locations
This clinical trial is studying nonsquamous non-small cell lung cancer (NSCLC). Participants in this study must have cancer...
Phase 3
Austin, Texas, United States and 96 other locations
with locally advanced or metastatic non-squamous Non-Small Cell Lung Cancer (NSCLC) with Epidermal Growth Factor Receptor (EGFR) ex...
Phase 3
Austin, Texas, United States and 204 other locations
in participants with chemotherapy-naive extensive-stage small cell lung cancer (ES-SCLC). Eligible participants will be stratified ...
Phase 3
Austin, Texas, United States and 123 other locations
This study looked at how effective the study drug (tepotinib) was at stopping the growth and spread of lung cancer. This study also...
Phase 2
Austin, Texas, United States and 176 other locations
combination with chemotherapy on progression-free survival (PFS) and overall survival (OS) in patients with untreated metastatic non-small cell lung...
Phase 3
Austin, Texas, United States and 223 other locations
The purpose of the study is to assess the efficacy of durvalumab plus tremelimumab in combination with chemotherapy compared with pembrolizumab in co...
Phase 3
Austin, Texas, United States and 71 other locations
Clinical trials
Research sites
Resources
Legal